ENDURONYL FORTE
Clinical safety rating: caution
Comprehensive clinical and safety monograph for ENDURONYL FORTE (ENDURONYL FORTE).
Enduronyl Forte is a combination of methyclothiazide, a thiazide diuretic that inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule, and deserpidine, a Rauwolfia alkaloid that depletes catecholamines from adrenergic nerve endings, resulting in reduced peripheral vascular resistance and CNS sedation.
| Metabolism | Methyclothiazide is not extensively metabolized and is excreted unchanged by the kidneys. Deserpidine is metabolized in the liver via hydrolysis and conjugation. |
| Excretion | Renal: ~50% unchanged; Biliary/Fecal: ~50% as metabolites and unchanged drug. |
| Half-life | Terminal elimination half-life: 24-48 hours (avg. 36 h); due to long half-life, requires caution in renal impairment. |
| Protein binding | ~90% bound to plasma proteins (primarily albumin). |
| Volume of Distribution | Vd: 2-4 L/kg; indicates extensive tissue distribution. |
| Bioavailability | Oral: ~70% (well absorbed, but first-pass metabolism reduces bioavailability). |
| Onset of Action | Oral: 2-4 hours (antihypertensive effect). |
| Duration of Action | Oral: 12-24 hours; clinical effect may persist up to 48 h due to slow elimination. |
| Molecular Weight | 415 |
Oral: Initial 2.5-5 mg once daily; increase as needed to maximum 20 mg once daily.
| Dosage form | TABLET |
| Renal impairment | GFR 30-59 mL/min: 1.25-2.5 mg once daily; GFR 15-29 mL/min: 0.625-1.25 mg once daily; GFR <15 mL/min: not recommended. |
| Liver impairment | Child-Pugh A: no adjustment; Child-Pugh B: reduce dose by 50%; Child-Pugh C: contraindicated. |
| Pediatric use | Not recommended for patients <18 years due to lack of safety data. |
| Geriatric use | Start at 1.25 mg once daily; increase slowly to avoid hypotension and electrolyte imbalance. |
| 1st trimester | Enduronyl Forte is contraindicated in first trimester due to risk of fetal hypotension, oligohydramnios, and possible teratogenic effects. |
| 2nd trimester | Use with caution in second trimester; monitor fetal growth and amniotic fluid volume. May cause fetal bradycardia, growth retardation, and oligohydramnios. |
| 3rd trimester | Contraindicated in third trimester due to risk of neonatal hypotension, hypoglycemia, bradycardia, and acute renal failure. |
Clinical note
Comprehensive clinical and safety monograph for ENDURONYL FORTE (ENDURONYL FORTE).
| Placental transfer | The thiazide component (methyclothiazide) crosses the placenta and may cause fetal/neonatal electrolyte disturbances. Deserpidine (rauwolfia alkaloid) also crosses the placenta and can cause fetal bradycardia. |
| Breastfeeding | Enduronyl Forte (methyclothiazide/deserpidine) is excreted into breast milk in low amounts; diuretics may suppress lactation. Monitor infant for diuretic effects and electrolyte disturbances. Consider alternative agents. |
■ FDA Black Box Warning
None
| Serious Effects |
Hypersensitivity to thiazides or sulfonamide derivativesAnuriaSevere renal impairment (eGFR <30 mL/min)Hepatic coma or pre-comaConcurrent use of MAO inhibitors (deserpidine component)Breastfeeding (relative caution)
| Precautions | May cause electrolyte disturbances including hypokalemia, hyponatremia, and hypomagnesemia, May precipitate azotemia in patients with renal impairment, May cause severe mental depression and suicidal ideation with deserpidine, May increase lithium toxicity, May cause photosensitivity and systemic lupus erythematosus exacerbation, Use caution in patients with hepatic disease due to risk of hepatic coma, May cause hyperglycemia and hyperuricemia |
| Food/Dietary | Avoid excessive intake of foods high in sodium (processed foods, canned soups, salty snacks) as they can counteract antihypertensive effects. Thiazide diuretics cause potassium loss; consume potassium-rich foods (bananas, oranges, spinach) or consider potassium supplements if advised by doctor. Limit alcohol and caffeine as they may exacerbate hypotension. Grapefruit juice may alter drug metabolism; consult healthcare provider. |
Loading safety data…
| Lactation Rating | L3 (Moderately Safe) |
| Teratogenic Risk | ENDURONYL FORTE (methylothiazide 5mg, deserpidine 0.5mg) is contraindicated in pregnancy. First trimester: Thiazide diuretics cross placenta and are associated with increased risk of congenital anomalies, particularly neural tube defects and cardiovascular malformations. Second and third trimesters: Risk of fetal/neonatal adverse effects including electrolyte disturbances, thrombocytopenia, jaundice, and hypotension. Deserpidine (Rauwolfia alkaloid) may cause neonatal bradycardia, respiratory depression, and hypotonia if used near term. |
| Fetal Monitoring | Monitor maternal blood pressure, serum electrolytes (especially sodium, potassium), uric acid, and renal function. Fetal monitoring includes ultrasound for growth and amniotic fluid volume (risk of oligohydramnios). Neonatal monitoring for hypoglycemia, electrolyte disturbances, and thrombocytopenia. |
| Fertility Effects | Limited data. Thiazides may cause sexual dysfunction in males but no direct evidence of impaired fertility. Reserpine can cause decreased libido and gynecomastia. Effects on female fertility are unknown. |
| Clinical Pearls | Enduronyl Forte is a combination antihypertensive containing methyclothiazide (a thiazide diuretic) and deserpidine (a rauwolfia alkaloid). Monitor for hypokalemia, hyponatremia, and hyperuricemia due to thiazide component. Deserpidine may cause depression, bradycardia, and nasal congestion. Avoid in patients with history of mental depression, peptic ulcer, or pheochromocytoma. Titrate slowly to prevent sudden hypotension. |
| Patient Advice | Take medication exactly as prescribed; do not skip doses or double up. · Avoid sudden discontinuation; may cause withdrawal symptoms like anxiety and dizziness. · Monitor for signs of potassium loss: muscle weakness, cramps, or irregular heartbeat. · Report symptoms of depression, mood changes, or suicidal thoughts to your doctor. · Avoid alcohol as it can worsen hypotension and drowsiness. · Maintain adequate hydration but avoid excessive fluid intake unless directed. · Use sun protection; may increase sensitivity to sunlight. |